Israel Englander’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,000
Closed -$715K 6138
2024
Q3
$715K Buy
+10,000
New +$706K ﹤0.01% 4543
2024
Q2
Sell
-10,000
Closed -$536K 6122
2024
Q1
$536K Buy
+10,000
New +$538K ﹤0.01% 4765
2022
Q3
Sell
-5,200
Closed -$292K 7218
2022
Q2
$292K Hold
5,200
﹤0.01% 5402
2022
Q1
$384K Sell
5,200
-54,800
-91% -$3.81M ﹤0.01% 5329
2021
Q4
$4.33M Buy
+60,000
New +$4.36M ﹤0.01% 3045
2021
Q1
Sell
-10,000
Closed -$652K 6138
2020
Q4
$652K Buy
+10,000
New +$575K ﹤0.01% 4013
2020
Q1
Sell
-20,000
Closed -$1.18M 4091
2019
Q4
$1.18M Buy
+20,000
New +$1.09M ﹤0.01% 2930
2018
Q3
Sell
-100,000
Closed -$5.05M 4043
2018
Q2
$5.05M Buy
100,000
+90,000
+900% +$4.69M 0.01% 1813
2018
Q1
$498K Buy
+10,000
New +$470K ﹤0.01% 3022

Other funds holding GMED

Israel Englander's GMED Position: Q2 2026 in Review

Israel Englander reduced its Globus Medical (GMED) stake by 98% in Q2 2026, selling an estimated $137M and leaving 28,835 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3715.

Israel Englander first reported a position in GMED in Q2 2013 and has held it in 47 quarters since. The position peaked at $142M in Q1 2026. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Israel Englander held 28,835 shares of Globus Medical worth $2.28M as of Q2 2026.
  • Israel Englander sold 1,614,517 Globus Medical shares in Q2 2026, an estimated $137M.
  • Globus Medical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3715 holding.
  • Israel Englander first reported a position in Globus Medical in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Globus Medical position peaked at $142M in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.